HA Skin Boosters vs Polynucleotides: What Practitioners Need to Understand

Ask ten clients what they want from a skin treatment and you will probably hear similar answers: better hydration, healthier-looking skin, fewer fine lines and an improvement in overall skin quality.

That does not mean they all need the same treatment.

For practitioners, one of the more important distinctions to understand is the difference between HA skin boosters and polynucleotides. They are sometimes discussed as though they are interchangeable, but their properties, treatment rationale and the way they may fit into a treatment plan are different.

Understanding that difference makes consultation easier and helps practitioners move away from choosing a product simply because it is currently popular.

What are HA skin boosters?

Hyaluronic acid is naturally present within the body and has a strong affinity for water. In aesthetics, injectable HA products can be used in several different ways depending on their formulation.

Traditional dermal fillers tend to be associated with structural correction or volume. Skin boosters are generally positioned differently: their primary purpose is improving aspects of skin quality rather than significantly changing facial shape.

Research into injectable HA treatments has reported improvements particularly in skin hydration and radiance, although outcomes vary by product, technique and study design.

That distinction matters.

A client asking for their skin to look fresher and more hydrated is presenting a very different objective from somebody seeking projection, contour or replacement of lost facial volume.

What are polynucleotides?

Polynucleotides, usually shortened to PN, have become increasingly prominent within aesthetic medicine.

Rather than approaching every skin concern primarily through hydration or volume, PN treatments are frequently discussed within the context of regenerative skin treatments and improvement in skin quality.

Clinical research is continuing to develop. Studies have reported improvements in areas including wrinkles, texture, hydration and elasticity, although—as with many developing areas of aesthetic medicine—the evidence base should continue to be interpreted alongside product-specific data and good clinical judgement.

This is one reason practitioners should understand the science rather than relying on social-media terminology such as “salmon DNA treatment”.

Clients rarely need the marketing description. They need the practitioner to understand what is being used, why it has been selected and what a realistic outcome might be.

HA skin boosters vs polynucleotides: which is better?

This is usually the wrong question.

A better question is:

What are we trying to improve?

A client may present with dehydration, crepey texture, early signs of ageing, fine lines, reduced skin quality or several concerns at the same time.

The appropriate treatment therefore depends on assessment rather than which injectable happens to be receiving the most attention online.

HA skin boosters may form part of a plan where hydration and skin quality are priorities. Polynucleotides may be considered where the treatment rationale is more focused around regenerative approaches to improving the appearance and quality of the skin.

Neither should automatically be viewed as a replacement for the other.

In some practices, they may even sit within different stages of a longer-term skin plan.

Product knowledge matters

The category printed on the box is only the beginning.

Practitioners should understand the particular product they intend to use, including:

• formulation
• intended use
• treatment areas
• manufacturer guidance
• contraindications
• injection technique
• expected response
• possible complications
• treatment intervals
• aftercare

Two products described casually as “skin boosters” may not necessarily behave in the same way.

This is why advanced practitioners need to understand products at a deeper level than simply knowing a treatment protocol.

Consultation should come before product selection

One of the easiest habits to fall into in aesthetics is starting the consultation with the treatment.

A client asks for polynucleotides, so the practitioner begins planning polynucleotides.

But why does the client want them?

Perhaps they saw a before-and-after result on Instagram. Perhaps somebody told them PN would remove their dark circles. Perhaps they actually dislike skin laxity, loss of facial volume or pigmentation—none of which should automatically be reduced to a single fashionable injectable.

The practitioner’s job is to identify the concern first.

Only then should product selection begin.

Developing better treatment judgement

Advanced aesthetics is not simply about learning how to place a needle.

It is about understanding why, when and for whom a treatment is appropriate.

The greater your treatment menu becomes, the more important that judgement becomes.

For practitioners wanting to strengthen their theoretical understanding of these treatments, Cole Aesthetics Academy offers dedicated HA Skin Boosters and PN Skin Boosters masterclasses for qualified aesthetic practitioners. The Academy’s courses are intended to extend existing practitioner knowledge and do not replace hands-on supervised clinical training or individual scope-of-practice requirements.

Because the aim is not simply to offer more treatments.

It is to become better at deciding which treatment should be offered in the first place.